Insider · CIK 0001641580

Beeler Brian K

Reports to the SEC for 1 company · DUBLIN, L2

sec.gov

Transactions

Companies

Filings

CIK

0001641580

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-09-17	Horizon Therapeutics Public Ltd CoS Sale	EVP, General Counsel	SSale	−28.1K sh	$107.91	−$3.04M	62,775
2021-08-16	Horizon Therapeutics Public Ltd CoS Sale	EVP, General Counsel	SSale	−74.9K sh	$106.00	−$7.94M	90,918
2021-08-16	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, General Counsel	MExercise/Conversion	+65.9K sh	$22.14	+$1.46M	165,816
2021-08-16	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)M Exercise/Conversion	EVP, General Counsel	MExercise/Conversion	−65.9K sh	—	—	0
2021-07-28	Horizon Therapeutics Public Ltd CoA Award	EVP, General Counsel	AAward	+5,806 sh	—	—	102,532
2021-07-28	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award	EVP, General Counsel	AAward	+11.6K sh	—	—	11,612
2021-07-28	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, General Counsel	FTax Payment	−2,573 sh	$102.50	−$264K	99,959
2021-03-31	Horizon Therapeutics Public Ltd CoS Sale	EVP, General Counsel	SSale	−26.8K sh	$90.12	−$2.42M	95,677
2021-02-17	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, General Counsel	FTax Payment	−696 sh	$87.17	−$60.7K	122,521
2021-02-17	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award	EVP, General Counsel	AAward	+11.6K sh	—	—	11,610
2021-02-17	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award	EVP, General Counsel	AAward	+3,144 sh	—	—	3,144
2021-02-17	Horizon Therapeutics Public Ltd CoA Award	EVP, General Counsel	AAward	+1,571 sh	—	—	123,217
2021-01-21	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, General Counsel	FTax Payment	−1,826 sh	$77.43	−$141K	121,646
2021-01-21	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, General Counsel	MExercise/Conversion	+4,120 sh	—	—	123,472
2021-01-21	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)M Exercise/Conversion	EVP, General Counsel	MExercise/Conversion	−4,120 sh	—	—	4,120
2021-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, General Counsel	MExercise/Conversion	−12.3K sh	—	—	12,261
2021-01-05	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, General Counsel	FTax Payment	−44.2K sh	$73.28	−$3.24M	119,352
2021-01-05	Horizon Therapeutics Public Ltd CoA Award	EVP, General Counsel	AAward	+60.3K sh	—	—	163,537
2021-01-05	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, General Counsel	MExercise/Conversion	+39.2K sh	—	—	103,224
2021-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, General Counsel	MExercise/Conversion	−9,675 sh	—	—	19,352
2021-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, General Counsel	MExercise/Conversion	−17.3K sh	—	—	0
2021-01-04	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)A Award	EVP, General Counsel	AAward	+24.4K sh	—	—	24,449
2020-09-04	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)M Exercise/Conversion	EVP, General Counsel	MExercise/Conversion	−14.1K sh	—	—	65,857
2020-09-04	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, General Counsel	MExercise/Conversion	+14K sh	$7.61	+$107K	49,885
2020-09-04	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, General Counsel	MExercise/Conversion	+14.1K sh	$22.14	+$313K	64,028
2020-09-04	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)M Exercise/Conversion	EVP, General Counsel	MExercise/Conversion	−14K sh	—	—	0
2020-06-01	Horizon Therapeutics Public Ltd CoS Sale	EVP, General Counsel	SSale	−2,370 sh	$50.23	−$119K	35,885
2020-05-06	Horizon Therapeutics Public Ltd CoS Sale	EVP, General Counsel	SSale	−48K sh	$40.80	−$1.96M	37,206
2020-04-29	Horizon Therapeutics Public Ltd CoS Sale	EVP, General Counsel	SSale	−15.9K sh	$35.02	−$556K	85,206
2020-04-16	Horizon Therapeutics Public Ltd CoS Sale	EVP, General Counsel	SSale	−9,000 sh	$32.51	−$293K	101,086
2020-04-07	Horizon Therapeutics Public Ltd CoS Sale	EVP, General Counsel	SSale	−297 sh	$32.50	−$9,652.5	110,086
2020-04-06	Horizon Therapeutics Public Ltd CoS Sale	EVP, General Counsel	SSale	−2,370 sh	$32.50	−$77K	110,383
2020-02-19	Horizon Therapeutics Public Ltd CoA Award	EVP, General Counsel	AAward	+10.2K sh	—	—	117,287
2020-02-19	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, General Counsel	FTax Payment	−4,534 sh	$36.06	−$163K	112,753
2020-02-19	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award	EVP, General Counsel	AAward	+20.5K sh	—	—	20,465
2020-01-21	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award	EVP, General Counsel	AAward	+9,810 sh	—	—	9,810
2020-01-21	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, General Counsel	FTax Payment	−1,825 sh	$38.25	−$69.8K	107,055
2020-01-21	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock Units (PSUs)A Award	EVP, General Counsel	AAward	+8,240 sh	—	—	8,240
2020-01-21	Horizon Therapeutics Public Ltd CoA Award	EVP, General Counsel	AAward	+4,119 sh	—	—	108,880
2020-01-21	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, General Counsel	FTax Payment	−2,173 sh	$38.25	−$83.1K	107,491
2020-01-21	Horizon Therapeutics Public Ltd CoA Award	EVP, General Counsel	AAward	+4,903 sh	—	—	109,664
2020-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, General Counsel	MExercise/Conversion	−12.3K sh	—	—	24,522
2020-01-05	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, General Counsel	FTax Payment	−21.7K sh	$36.10	−$783K	104,761
2020-01-05	Horizon Therapeutics Public Ltd CoA Award	EVP, General Counsel	AAward	+19K sh	—	—	126,451
2020-01-05	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, General Counsel	MExercise/Conversion	+29.5K sh	—	—	107,437
2020-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, General Counsel	MExercise/Conversion	−17.3K sh	—	—	17,260
2020-01-03	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)A Award	EVP, General Counsel	AAward	+29K sh	—	—	29,027
2019-12-18	Horizon Therapeutics Public Ltd CoS Sale	EVP, General Counsel	SSale	−6,716 sh	$35.00	−$235K	77,917
2019-11-25	Horizon Therapeutics Public Ltd CoS Sale	EVP, General Counsel	SSale	−4,969 sh	$32.50	−$161K	89,633
2019-11-25	Horizon Therapeutics Public Ltd CoS Sale	EVP, General Counsel	SSale	−5,000 sh	$32.52	−$163K	84,633

Recent filings

Accepted (ET)
Sep 174
Beeler Brian K0001209191-21-056671
SEC(opens sec.gov)
Aug 174
Beeler Brian K0001209191-21-051912
SEC(opens sec.gov)
Jul 304
Beeler Brian K0001209191-21-048786
SEC(opens sec.gov)
Apr 24
Beeler Brian K0001209191-21-024687
SEC(opens sec.gov)
Feb 194
Beeler Brian K0001209191-21-012409
SEC(opens sec.gov)
Jan 224
Beeler Brian K0001209191-21-005001
SEC(opens sec.gov)
Jan 64
Beeler Brian K0001209191-21-002412
SEC(opens sec.gov)

Companies

Horizon Therapeutics Public Ltd CoEVP, General Counsel

Address

C/O HORIZON PHARMA PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD

DUBLIN, L2, 4